Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824
Peter Atadja(University of Health and Allied Sciences), Stacy Remiszewski(ALS Biopharma (United States)), Lakshmi Yeleswarapu(Novartis (United States)), Nagarajan Chandramouli(Novartis (United States)), Arthur Wu(Novartis (United States)), Nancy Trogani, Heather Walker(Boston University), Richard Versace(Novartis (United States)), Meier Hsu(Memorial Sloan Kettering Cancer Center), Lin Gao(ShenZhen People’s Hospital), Lidia Sambucetti(Summit Oaks Hospital), Paul Kwon, Kenneth W. Bair(Novartis (United States)), Peter Lassota, Dalia Cohen(Regulus Therapeutics (United States)), Alexander W. Wood(University of California San Diego), Larry B. Perez(Novartis (United States))
Cited by 134
Related Papers
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
|Journal of Clinical Oncology|2009|410
Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects
|Journal of Biological Chemistry|1999|393
Design of a genome-wide siRNA library using an artificial neural network
|Nature Biotechnology|2005|386
Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells
|Proceedings of the National Academy of Sciences|2003|374